|Age:||12 years or older|
|Keywords:||cystic fibrosis, F508del Mutation, genetic mutation|
|Type:||Drug study, Phase 3|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.